Literature DB >> 27008871

Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.

Frédéric Lamoth1,2,3,4, Lauro Damonti3, Barbara D Alexander5,2.   

Abstract

No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤0.5 μg/ml was significantly associated with better 6-week outcomes.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27008871      PMCID： PMC4879309          DOI： 10.1128/JCM.00318-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors:  Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

2.  Improvement in the outcome of invasive fusariosis in the last decade.

Authors:  M Nucci; K A Marr; M J G T Vehreschild; C A de Souza; E Velasco; P Cappellano; F Carlesse; F Queiroz-Telles; D C Sheppard; A Kindo; S Cesaro; N Hamerschlak; C Solza; W J Heinz; M Schaller; A Atalla; S Arikan-Akdagli; H Bertz; C Galvão Castro; R Herbrecht; M Hoenigl; G Härter; N E U Hermansen; A Josting; L Pagano; M J C Salles; S B Mossad; D Ogunc; A C Pasqualotto; V Araujo; P F Troke; O Lortholary; O A Cornely; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

3.  A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

Authors:  F Lanternier; E Dannaoui; G Morizot; C Elie; D Garcia-Hermoso; M Huerre; D Bitar; F Dromer; O Lortholary
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Authors:  Dimitrios P Kontoyiannis; Kieren A Marr; Benjamin J Park; Barbara D Alexander; Elias J Anaissie; Thomas J Walsh; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa Papanicolaou; Thomas F Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

Review 5.  Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species.

Authors:  Peter C Iwen; Stephanie D Schutte; Diana F Florescu; Rhonda K Noel-Hurst; Lynne Sigler
Journal:  Med Mycol       Date:  2012-04-23       Impact factor: 4.076

6.  Epidemiology of invasive mold infections in lung transplant recipients.

Authors:  C T Doligalski; K Benedict; A A Cleveland; B Park; G Derado; P G Pappas; J W Baddley; D W Zaas; M T Harris; B D Alexander
Journal:  Am J Transplant       Date:  2014-04-11       Impact factor: 8.086

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 8.  Our 2014 approach to mucormycosis.

Authors:  Daniela Tacke; Philipp Koehler; Birgid Markiefka; Oliver A Cornely
Journal:  Mycoses       Date:  2014-05-15       Impact factor: 4.377

9.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Authors:  O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; T Freiberger; J Guinea; J Guarro; S de Hoog; W Hope; E Johnson; S Kathuria; M Lackner; C Lass-Flörl; O Lortholary; J F Meis; J Meletiadis; P Muñoz; M Richardson; E Roilides; A M Tortorano; A J Ullmann; A van Diepeningen; P Verweij; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

10.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Authors:  A M Tortorano; M Richardson; E Roilides; A van Diepeningen; M Caira; P Munoz; E Johnson; J Meletiadis; Z-D Pana; M Lackner; P Verweij; T Freiberger; O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; J Guinea; J Guarro; S de Hoog; W Hope; S Kathuria; O Lortholary; J F Meis; A J Ullmann; G Petrikkos; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067
View more
  12 in total

Review 1.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.

Authors:  A P Bellanger; J P Cervoni; J F Faucher; D Weil-Verhoeven; M Ginet; E Deconinck; F Grenouillet
Journal:  Mycopathologia       Date:  2017-04-01       Impact factor: 2.574

Review 3.  Challenges in the diagnosis and treatment of mucormycosis.

Authors:  A Skiada; C Lass-Floerl; N Klimko; A Ibrahim; E Roilides; G Petrikkos
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

Review 4.  Therapy of Mucormycosis.

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Amalia Anastasopoulou; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2018-07-31

5.  Characteristics and risk factors for mortality of invasive non-Aspergillus mould infections in patients with haematologic diseases: A single-centre 7-year cohort study.

Authors:  Hyeon-Jeong Lee; Sung-Yeon Cho; Dong-Gun Lee; Chulmin Park; Hye-Sun Chun; Yeon-Joon Park
Journal:  Mycoses       Date:  2019-12-10       Impact factor: 4.377

Review 6.  Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.

Authors:  Frederic Lamoth; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2020-12-30

7.  Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan.

Authors:  Somia Iqtadar; Masooma Hashmat; Muhammad Nabeel Akbar Chaudhry; Sami Ullah Mumtaz; Sajid Abaidullah; Domingo A Pascual-Figal; Amjad Khan
Journal:  Ther Adv Infect Dis       Date:  2022-05-06

8.  Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Scedosporium and Fusarium spp.

Authors:  Katerina Vikelouda; Maria Simitsopoulou; Lemonia Skoura; Charalampos Antachopoulos; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

Review 9.  Rare fungal infectious agents: a lurking enemy.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  F1000Res       Date:  2017-10-31

Review 10.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.